Spire Healthcare Group PLC
LSE:SPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SKM Egg Products Export India Ltd
NSE:SKMEGGPROD
|
IN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (8.4), the stock would be worth GBX200.66 (22% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.9 | GBX164.2 |
0%
|
| 3-Year Average | 8.4 | GBX200.66 |
+22%
|
| 5-Year Average | 8.2 | GBX194.65 |
+19%
|
| Industry Average | 0 | GBX0.58 |
-100%
|
| Country Average | 0 | GBX0.47 |
-100%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
GBX2B
|
/ |
Jan 2026
£265.5m
|
= |
|
|
GBX2B
|
/ |
Dec 2026
£294.2m
|
= |
|
|
GBX2B
|
/ |
Dec 2027
£327.7m
|
= |
|
|
GBX2B
|
/ |
Dec 2028
£334.2m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Spire Healthcare Group PLC
LSE:SPI
|
661.3m GBP | 6.9 | 40.3 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
107.6B USD | 9.5 | 16.1 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 31.9 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
24B ZAR | 9.4 | 14.3 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.8B MYR | 15.3 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
18B ZAR | 18.4 | 4.7 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
85.3B BRL | 7.8 | 18.2 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
16.6B USD | 5.8 | 11.9 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
91.9B CNY | 20.8 | 29.3 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 30 | 61.9 | |
| US |
|
Universal Health Services Inc
NYSE:UHS
|
11B USD | 5.7 | 7.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 743.2 |
Other Multiples
Spire Healthcare Group PLC
Glance View
Spire Healthcare Group PLC, a notable player in the UK’s independent hospital sector, operates an extensive network of private hospitals and clinics. Born out of Bupa’s acute care business in 2007, the company has carved a niche by offering a wide array of medical services, including elective surgeries, diagnostic tests, and specialist consultations. Spire’s revenue model revolves around providing these healthcare services both to self-paying patients and those insured with private medical insurance. A considerable portion of its income is also derived from contracts with the National Health Service (NHS), where Spire steps in to help reduce the public healthcare system’s waiting times. This dual-source revenue model allows Spire to balance its operations among private and public healthcare sectors effectively. The company's operations are anchored in a commitment to quality care, which is pivotal in sustaining its reputation and patient trust. Each healthcare facility is equipped with cutting-edge medical technology and staffed by experienced healthcare professionals, ensuring high standards of treatment and customer service. Spire’s strategic focus on investing in medical infrastructure and skilled personnel enables it to deliver specialized services that attract a broad demographic, from routine procedures to complex surgeries. As the healthcare landscape evolves, Spire Healthcare continues to adapt, striving to expand its service offerings and affordable healthcare solutions, whilst ensuring its hospitals and clinics remain synonymous with clinical excellence and patient satisfaction. This strategy appears designed not just to maintain its market position, but to meet the increasing demand for diverse and comprehensive healthcare services in the UK.